Industries > Pharma > Global OTC Pharmaceutical Market Forecast 2019-2029

Back to Pharma Reports

Global OTC Pharmaceutical Market Forecast 2019-2029

Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others

PUBLISHED: 31 July 2019

PAGES: 212

PRODUCT CODE: PHA0459

SUBMARKET: Pharma Therapeutic Drugs

SKU: PHA0459 Categories: Pharma, Pharma, Therapeutic Drugs Tags: PHA0459, PHA0461, PHA0465, PHA0520, PHA0526, PHA0527, PHA0528, PHA0701, PHA0720

The global OTC Pharmaceuticals market is estimated to be $162.64bn in 2018 and is expected to grow at a CAGR of 6.5% during the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 212-page report you will receive 100 tables and 103 figures- all unavailable elsewhere.

The 212-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global OTC Pharmaceutical Market forecasts from 2019-2029

• This report breaks down the revenue forecast of the Global OTC Pharmaceutical by product:
• Analgesics
• Cough, cold and allergy products
• Dermatological products
• Gastrointestinal products
• Eye Care
• Smoking Cessation Aids
• Other products

Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and RoW

• This report provides individual revenue forecasts to 2029 for these regional and national markets:
• North America: the US, Canada, Mexico
• South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
• Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
• Rest of the World: Middle East, Africa, Other Countries

Each regional market is further broken down by product.

• Our study provides a SWOT analysis and Porter’s Five Forces analysis of the Global OTC Pharmaceutical market

• This report discusses the leading companies in the Global OTC Pharmaceutical market
• Bayer AG
• Cipla, Inc.
• Daiichi Sankyo Co., Ltd
• GlaxoSmithKline (GSK) Consumer Care
• Johnson & Johnson
• Perrigo Company PLC
• Pfizer Inc.
• Procter & Gamble
• Reckitt Benckiser Group PLC
• Sanofi S.A

• Key Questions Answered by this Report:
• How is the OTC pharmaceuticals market evolving?
• What is driving and restraining the OTC pharmaceuticals market growth?
• What are the market shares of the leading segments within the OTC pharmaceuticals market in 2018?
• How will the leading products in the OTC pharmaceuticals market grow over the forecast period and how much revenue will they account for in 2029?
• Which therapies will be the main drivers of the overall market from 2018 to 2029?
• How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?
• Who are the leading OTC pharmaceuticals companies, and what are their prospects over the forecast period?
• What are the predictions for M&A activity, consolidation for existing players and the potential prospects for new market entrants?

Visiongain’s study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.

Buy our report today Global OTC Pharmaceutical Market Forecast 2019-2029: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help sara.peerun@visiongain.com

1. Report Overview

1.1 The OTC Pharmaceuticals Market Overview

1.2 Research Methodology

1.2.1 Secondary Research

1.2.2 Market Evaluation & Forecasting Methodology

1.3 Global OTC Pharmaceutical Market Segmentation

1.4 Why You Should Read This Report

1.5 How this report delivers?

1.6 Key Questions Answered by This Analytical Report

1.7 Frequently Asked Questions (FAQ)

1.8 Who is This Report For?

1.9 Associated Visiongain Reports

1.10 About Visiongain

2. Introduction to OTC Pharmaceuticals

2.1 What Are OTC Pharmaceuticals?

2.2 Classification of OTC Pharmaceuticals

2.3 What are the Requirements for an OTC Pharmaceutical Drug?

2.4 OTC Switching

2.4.1 How Is a Drug Switched from Prescription to OTC?

2.4.2 Manufacturing and Distribution of OTC Pharmaceuticals

2.5 Regulation of OTC Pharmaceuticals

2.5.1 Regulation of OTC Pharmaceuticals in the US

2.5.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs

2.5.3 Regulations of OTC Pharmaceuticals in Europe

2.5.4 Regulation of OTC Pharmaceuticals in China

2.5.5 Regulation of OTC Pharmaceuticals in Other Countries

3. Global OTC Pharmaceutical Market Forecast 2019-2029

3.1 The Current State of the OTC Pharmaceuticals Market

4. Global OTC Pharmaceutical Market by Product: Market Forecast 2019 - 2029

4.1 Overview

4.2 Cough, Cold and Allergy

4.2.1 Anti-Allergy Products

4.2.2 Market size and forecast 2019-2029

4.3 Analgesics

4.3.1 Internal Analgesics

4.3.2 External Analgesics

4.3.3 Market size and forecast 2019-2029

4.4 Gastrointestinal

4.4.1 Market size and forecast 2019-2029

4.5 Dermatological

4.5.1 Minor Cuts and Wounds

4.5.2 Acne

4.5.3 Rashes, Itchy Skin, and Dermatitis/Eczema

4.5.4 Cold Sores

4.5.5 Warts

4.5.6 Fungal Skin Infections

4.5.7 Haemorrhoids

4.5.8 Other Dermatological Products

4.5.9 Market size and forecast 2018-2029

4.6 Eye Care

4.6.1 Dry Eye Syndrome

4.6.2 Bacterial Conjunctivitis

4.6.3 Ocular Allergy and Allergic Conjunctivitis

4.6.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis

4.6.5 Market size and forecast 2019-2029

4.7 Smoking Cessation Aids

4.7.1 Market size and forecast 2019-2029

4.8 Other Products

4.8.1 Market size and forecast 2019-2029

5. Global OTC Pharmaceutical Market by National Market: Market Forecast 2019 - 2029

5.1 Global OTC Pharmaceuticals Market: Regional Forecast, 2019-2029

5.2 North American OTC Pharmaceuticals Market Forecasts 2019-2029

5.2.1 North American OTC Pharmaceuticals Market Forecasts by Country 2019-2029

5.2.2 USA OTC Pharmaceuticals Market Forecasts 2019-2029

5.2.3 Canada OTC Pharmaceuticals Market Forecasts 2019-2029

5.2.4 Mexico OTC Pharmaceuticals Market Forecasts 2019-2029

5.2.5 North American OTC Pharmaceuticals Market Forecasts by Product 2019-2029

5.3 South American OTC Pharmaceuticals Market Forecasts 2019-2029

5.3.1 South American OTC Pharmaceuticals Market Forecasts by Country 2019-2029

5.3.2 Brazil OTC Pharmaceuticals Market Forecasts 2019-2029

5.3.3 Argentina OTC Pharmaceutical Market Forecasts 2019-2029

5.3.4 Paraguay OTC Pharmaceuticals Market Forecasts 2019-2029

5.3.5 Bolivia OTC Pharmaceuticals Market Forecasts 2019-2029

5.3.6 Rest of South America OTC Pharmaceuticals Market Forecasts 2019-2029

5.3.7 South American OTC Pharmaceuticals Market Forecasts by Product 2019-2029

5.4 European OTC Pharmaceuticals Market Forecasts 2019-2029

5.4.1 Europe OTC Pharmaceuticals Market Forecasts by Country 2019-2029

5.4.2 Germany OTC Pharmaceuticals Market Forecasts 2019-2029

5.4.3 France OTC Pharmaceuticals Market Forecasts 2019-2029

5.4.4 U.K. OTC Pharmaceuticals Market Forecasts 2019-2029

5.4.5 Italy OTC Pharmaceuticals Market Forecasts 2019-2029

5.4.6 Spain OTC Pharmaceuticals Market Forecasts 2019-2029

5.4.7 Rest of Europe OTC Pharmaceuticals Market Forecasts 2019-2029

5.4.8 Europe OTC Pharmaceuticals Market Forecasts by Product 2019-2029

5.5 Asia-Pacific OTC Pharmaceuticals Market Forecasts 2019-2029

5.5.1 Asia-Pacific OTC Pharmaceuticals Market Forecasts by Country 2019-2029

5.5.2 Japan OTC Pharmaceuticals Market Forecasts 2019-2029

5.5.3 China OTC Pharmaceuticals Market Forecasts 2019-2029

5.5.4 India OTC Pharmaceuticals Market Forecasts 2019-2029

5.5.5 Australia OTC Pharmaceuticals Market Forecasts 2019-2029

5.5.6 Thailand OTC Pharmaceuticals Market Forecasts 2018-2029

5.5.7 Rest of Asia-Pacific OTC Pharmaceuticals Market Forecasts 2019-2029

5.5.8 Asia-Pacific OTC Pharmaceuticals Market Forecasts by Product 2018-2029

5.6 Rest of the World OTC Pharmaceuticals Market Forecasts 2019-2029

5.6.1 Rest of the World OTC Pharmaceuticals Market Forecasts by Country 2019-2029

5.6.2 Middle East OTC Pharmaceuticals Market Forecasts 2019-2029

5.6.3 Africa OTC Pharmaceuticals Market Forecasts 2019-2029

5.6.4 Other Countries OTC Pharmaceuticals Market Forecasts 2019-2029

5.6.5 Rest of the World OTC Pharmaceuticals Market Forecasts by Product 2019-2029

6. Qualitative Analysis of the OTC Pharmaceuticals Market

6.1 SWOT Analysis of the OTC Pharmaceuticals Market

6.2 Strengths

6.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption

6.3 Weaknesses

6.3.1 Pharma Companies Remain Focused on Prescription Drugs

6.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs

6.3.3 OTC Products are Vulnerable to Price Controls by Governments

6.3.4 Downward Cost Pressures of OTC Drugs

6.4 Opportunities

6.4.1 Demographic and Economic Changes Will Create Growth Opportunities

6.4.2 New OTC Switch Categories

6.4.3 Strong Growth in Emerging Markets

6.4.4 New Healthcare Technologies May enable OTC Approvals

6.4.5 Opportunities to Drive Sales via Social Media and Online Marketing

6.4.6 Self-Medication can Reduce the Under Treatment of Disease

6.5 Threats

6.5.1 Competition from Private-Label Brands Will Reduce Profitability

6.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products

6.5.3 Resistance to OTC Switching from Some Groups in Certain Countries

6.6 Porter’s Five Forces Analysis of the OTC Pharmaceuticals Market

6.7 Rivalry Among Competitors [High]

6.8 Threat of New Entrants [Medium]

6.9 Power of Suppliers [Low]

6.10 Power of Buyers [Medium]

6.11 Threats of Substitutes [Medium]

7. Leading Companies in the OTC Pharmaceuticals Market

7.1 Bayer AG

7.1.1 Bayer AG: Company Overview

7.1.2 Bayer AG: Financial Highlights

7.1.3 Bayer AG: Product Portfolio

7.1.4 Bayer AG: Recent Developments

7.2 GlaxoSmithKline PLC (GSK Consumer Care)

7.2.1 GlaxoSmithKline PLC: Company Overview

7.2.2 GlaxoSmithKline PLC: Financial Highlights

7.2.3 GlaxoSmithKline PLC: Product Portfolio

7.2.4 GlaxoSmithKline PLC: Recent Developments

7.3 Johnson & Johnson

7.3.1 Johnson & Johnson: Company Overview

7.3.2 Johnson & Johnson: Financial Highlights

7.3.3 Johnson & Johnson: Product Portfolio

7.3.4 Johnson & Johnson: Recent Developments

7.4 Perrigo Company PLC

7.4.1 Perrigo Company PLC: Company Overview

7.4.2 Perrigo Company PLC: Financial Highlights

7.4.3 Perrigo Company PLC: Product Portfolio

7.4.4 Perrigo Company PLC: Recent Developments

7.5 Daiichi Sankyo Company, Limited

7.5.1 Daiichi Sankyo Company, Limited: Company Overview

7.5.2 Daiichi Sankyo Company, Limited: Financial Highlights

7.5.3 Daiichi Sankyo Company Limited: Recent Developments

7.6 Pfizer Inc.

7.6.1 Pfizer Inc.: Company Overview

7.6.2 Pfizer Inc.: Financial Highlights

7.6.3 Pfizer Inc.: Product Portfolio

7.6.4 Pfizer Inc.: Recent Developments

7.7 The Procter & Gamble Company

7.7.1 The Procter & Gamble Company: Company Overview

7.7.2 The Procter & Gamble Company: Financial Highlights

7.7.3 The Procter & Gamble Company: Product Portfolio

7.7.4 The Procter & Gamble Company: Recent Developments

7.8 Sanofi S.A.

7.8.1 Sanofi S.A.: Company Overview

7.8.2 Sanofi S.A.: Financial Highlights

7.8.3 Sanofi S.A.: Product Portfolio

7.8.4 Sanofi S.A: Recent Developments

7.9 Reckitt Benckiser Group PLC

7.9.1 Reckitt Benckiser Group PLC: Company Overview

7.9.2 Reckitt Benckiser Group PLC: Financial Highlights

7.9.3 Reckitt Benckiser Group PLC: Product Portfolio

7.9.4 Reckitt Benckiser Group PLC: Recent Developments

7.10 Cipla, Inc.

7.10.1 Cipla Inc.: Company Overview

7.10.2 Cipla Inc.: Financial Highlights

7.10.3 Cipla Inc.: Product Portfolio

7.10.4 Cipla Inc.: Recent Developments

7.11 AstraZeneca plc

7.11.1 AstraZeneca plc: Company Overview

7.11.2 AstraZeneca plc: Financial Highlights

7.11.3 AstraZeneca plc: Product Portfolio

7.12 Bristol Myers Squibb

7.12.1 Bristol Myers Squibb: Company Overview

7.12.2 Bristol Myers Squibb: Financial Highlights

7.12.3 Bristol Myers Squibb: Product Portfolio

7.13 Dr. Reddy’s Laboratories Limited

7.13.1 Dr. Reddy’s Laboratories Limited: Company Overview

7.13.2 Dr. Reddy’s Laboratories Limited: Financial Highlights

7.13.3 Dr. Reddy’s Laboratories Limited: Product Portfolio

7.13.4 Dr. Reddy’s Laboratories Limited: Recent Developments

7.14 Eisai Co., Ltd.

7.14.1 Eisai Co., Ltd.: Company Overview

7.14.2 Eisai Co., Ltd.: Financial Highlights

7.14.3 Eisai Co., Ltd.: Product Portfolio

7.15 Mylan N.V.

7.15.1 Mylan N.V.: Company Overview

7.15.2 Mylan N.V.: Financial Highlights

7.15.3 Mylan N.V.: Product Portfolio

7.15.4 Mylan N.V.: Recent Developments

7.16 List of Key Players in global OTC Market

8. Conclusions

8.1 The World OTC Pharmaceuticals Market in 2018-2029

8.1.1 The Leading OTC Product Categories

8.1.2 Leading National Markets: Emerging Market Represent a Large Proportion

8.2 The Global OTC Pharmaceuticals Market Growth Factors

8.2.1 Potential OTC Switching, 2018-2029

8.2.2 Emerging OTC Markets

8.3 Concluding Remarks

Appendices

Associated Visiongain Reports

Visiongain Report Sales Order Form

About Visiongain

Visiongain report evaluation form

List of Table

Table 3.1 Global OTC Pharmaceutical Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 4.1 Global OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029

Table 4.2 OTC Cough, Cold and Allergy Active Ingredients, 2018

Table 4.3 Global OTC Pharmaceuticals Market for Cough, Cold and Allergy Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 4.4 Global OTC Pharmaceuticals Market for Cough, Cold and Allergy Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029

Table 4.5 OTC Internal Analgesic Active Ingredients, 2018

Table 4.6 OTC External Analgesic Active Ingredients, 2018

Table 4.7 Global OTC Pharmaceuticals Market for Analgesics Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 4.8 Global OTC Pharmaceuticals Market for Analgesics Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029

Table 4.9 Global OTC Pharmaceuticals Market for Gastrointestinal Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 4.10 Global OTC Pharmaceuticals Market for Gastrointestinal Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029

Table 4.11 OTC Antifungal Active Ingredients, 2018

Table 4.12 Global OTC Pharmaceuticals Market for Dermatological Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 4.13 Global OTC Pharmaceutical Market for Dermatological Market Forecast by Geography, ($bn, AGR%, CAGR%) 2019-2029

Table 4.14 OTC Dry Eye Syndrome Active Ingredients, 2018

Table 4.15 OTC Bacterial Conjunctivitis Active Ingredients, 2018

Table 4.16 OTC Ocular Allergy Active Ingredients, 2018

Table 4.17 Global OTC Pharmaceutical Market for Eye Care Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 4.18 Global OTC Pharmaceutical Market for Eye Care Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029

Table 4.19 OTC Smoking Cessation Aid Active Ingredients, 2018

Table 4.20 Global OTC Pharmaceuticals Market for Smoking Cessation Aids Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 4.21 Global OTC Pharmaceuticals Market for Smoking Cessation Aids Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029

Table 4.22 Global OTC Pharmaceuticals Market for Other Products Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 4.23 Global OTC Pharmaceuticals Market for Other Products Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029

Table 5.1 Global OTC Pharmaceuticals Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029

Table 5.2 North America OTC Pharmaceutical Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029

Table 5.3 USA OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.4 Canada OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 5.5 Mexico OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 5.6 North America OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029

Table 5.7 South America OTC Pharmaceuticals Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029

Table 5.8 Brazil OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 5.9 Argentina OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 5.10 Paraguay OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 5.11 Bolivia OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 5.12 Rest of South America OTC Pharmaceuticals Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 5.13 South America OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029

Table 5.14 European OTC Pharmaceuticals Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029

Table 5.15 Germany OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.16 France OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.17 U.K. OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.18 Italy OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.19 Spain OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.20 Rest of Europe OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.21 Europe OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029

Table 5.22 Asia-Pacific OTC Pharmaceuticals Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029

Table 5.23 Japan OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.24 China OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.25 India OTC Pharmaceuticals Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 5.26 Australia OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.27 Thailand OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.28 Rest of Asia-Pacific OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.29 Asia-Pacific OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029

Table 5.30 Rest of World OTC Pharmaceuticals Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029

Table 5.31 Middle East OTC Pharmaceuticals Market Forecast, ($bn, AGR%, CAGR%) 2019-2029

Table 5.32 Africa OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029

Table 5.33 Other Countries OTC Pharmaceuticals Market Forecast: Revenue ($bn, AGR%, CAGR%) 2019-2029

Table 5.34 Rest of the World OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029

Table 7.1 Bayer AG: Company Overview

Table 7.2 Bayer AG: Product Portfolio

Table 7.3 Bayer AG: Recent Developments

Table 7.4 GlaxoSmithKline PLC: Company Overview

Table 7.5 GlaxoSmithKline PLC: Product Portfolio

Table 7.6 GlaxoSmithKline PLC: Recent Developments

Table 7.7 Johnson & Johnson: Company Overview

Table 7.8 Johnson & Johnson: Product Portfolio

Table 7.9 Johnson & Johnson: Recent Developments

Table 7.10 Perrigo Company PLC: Company Overview

Table 7.11 Perrigo Company PLC: Product Portfolio

Table 7.12 Perrigo Company PLC: Recent Developments

Table 7.13 Daiichi Sankyo Company, Limited: Company Overview

Table 7.14 Daiichi Sankyo Company Limited: Recent Developments

Table 7.15 Pfizer Inc.: Company Overview

Table 7.16 Pfizer Inc.: Product Portfolio

Table 7.17 Pfizer Inc.: Recent Developments

Table 7.18 The Procter & Gamble Company: Company Overview

Table 7.19 The Procter & Gamble Company: Product Portfolio

Table 7.20 The Procter & Gamble Company: Recent Developments

Table 7.21 Sanofi S.A.: Company Overview

Table 7.22 Sanofi S.A.: Product Portfolio

Table 7.23 Sanofi S.A: Recent Developments

Table 7.24 Reckitt Benckiser Group PLC: Company Overview

Table 7.25 Reckitt Benckiser Group PLC: Product Portfolio

Table 7.26 Reckitt Benckiser Group PLC: Recent Developments

Table 7.27 Cipla Inc.: Company Overview

Table 7.28 Cipla Inc.: Product Portfolio

Table 7.29 Cipla Inc.: Recent Developments

Table 7.30 AstraZeneca plc: Company Overview

Table 7.31 AstraZeneca plc: Product Portfolio

Table 7.32 Bristol Myers Squibb: Company Overview

Table 7.33 Bristol Myers Squibb: Product Portfolio

Table 7.34 Dr. Reddy’s Laboratories Limited: Company Overview

Table 7.35 Dr. Reddy’s Laboratories Limited: Product Portfolio

Table 7.36 Dr. Reddy’s Laboratories Limited: Recent Developments

Table 7.37 Eisai Co., Ltd.: Company Overview

Table 7.38 Eisai Co., Ltd.: Product Portfolio

Table 7.39 Mylan N.V.: Company Overview

Table 7.40 Mylan N.V.: Product Portfolio

Table 7.41 Mylan N.V.: Recent Developments

Table 7.42 List of Key Players in Global OTC Pharmaceuticals Marke

List of Figure

Figure 2.1 The OTC Pharmaceutical Supply Chain, 2019

Figure 3.1 OTC Pharmaceuticals Market by Product: Revenue ($bn), 2019-2029

Figure 3.2 OTC Pharmaceutical Market by Geography: Revenue ($bn) 2019-2029

Figure 4.1 Global OTC Pharmaceuticals Market by Product; Market Share (%), 2018

Figure 4.2 Global OTC Pharmaceuticals Market by Product: Revenue Forecast ($bn) 2019-2029

Figure 4.3 Global OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast by Geography: Revenue ($bn) 2019-2029

Figure 4.4 Global OTC Pharmaceuticals Market for Analgesics Market Forecast by Geography: Revenue ($bn) 2019-2029

Figure 4.5 Global OTC Pharmaceutical Market for Gastrointestinal Market Forecast by Geography: Revenue ($bn) 2019-2029

Figure 4.6 Global OTC Pharmaceuticals Market for Dermatological Market Forecast by Geography: Revenue ($bn) 2019-2029

Figure 4.7 Global OTC Pharmaceuticals Market for Eye Care Market Forecast by Geography: Revenue ($bn) 2019-2029

Figure 4.8 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast by Geography: Revenue ($bn) 2019-2029

Figure 4.9 Global OTC Pharmaceuticals Market for Other Products Market Forecast by Geography: Revenue ($bn) 2019-2029

Figure 5.1 Global OTC Pharmaceuticals Market Forecast by Geography: Revenue ($bn) 2019-2029

Figure 5.2 Global OTC Pharmaceuticals Market by Geography: Market Share (%), 2018

Figure 5.3 North America OTC Pharmaceuticals Market Forecast by Country: Revenue ($bn) 2019-2029

Figure 5.4 North America OTC Pharmaceuticals Market by Country: Market Share (%), 2018

Figure 5.5 USA OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.6 Canada OTC Pharmaceutical Market Forecast: Revenue ($bn) 2019-2029

Figure 5.7 Mexico OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.8 North America OTC Pharmaceutical Market Forecast by Product: Revenue ($bn) 2019-2029

Figure 5.9 North America OTC Pharmaceutical Market by Product: Market Share (%), 2018

Figure 5.10 South America OTC Pharmaceutical Market Forecast by Country ($bn) 2019-2029

Figure 5.11 South America OTC Pharmaceuticals Market by Country: Market Share (%), 2018

Figure 5.12 Brazil OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.13 Argentina OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.14 Paraguay OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.15 Bolivia OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.16 Rest of South America OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.17 South America OTC Pharmaceuticals Market Forecast by Product: Revenue ($bn) 2019-2029

Figure 5.18 South America OTC Pharmaceuticals Market by Product: Market Share (%), 2018

Figure 5.19 Europe OTC Pharmaceuticals Market Forecast by Country ($bn) 2019-2029

Figure 5.20 Europe OTC Pharmaceutical Market by Country: Market Share (%), 2018

Figure 5.21 Germany OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.22 France OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.23 U.K. OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.24 Italy OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.25 Spain OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.26 Rest of Europe OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.27 Europe OTC Pharmaceuticals Market Forecast by Product: Revenue ($bn) 2019-2029

Figure 5.28 Europe OTC Pharmaceuticals Market by Product: Market Share (%), 2018

Figure 5.29 Asia-Pacific OTC Pharmaceuticals Market Forecast by Country: Revenue ($bn) 2019-2029

Figure 5.30 Asia-Pacific OTC Pharmaceutical Market by Country: Market Share (%), 2018

Figure 5.31 Japan OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.32 China OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.33 India OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.34 Australia OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.35 Thailand OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.36 Rest of Asia-Pacific OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.37 Asia-Pacific OTC Pharmaceuticals Market Forecast by Product: Revenue ($bn) 2019-2029

Figure 5.38 Asia-Pacific OTC Pharmaceutical Market by Product: Market Share (%), 2018

Figure 5.39 Rest of the World OTC Pharmaceuticals Market Forecast by Country: Revenue ($bn) 2019-2029

Figure 5.40 Rest of the World OTC Pharmaceuticals Market by Country: Market Share (%), 2018

Figure 5.41 Middle East OTC Pharmaceuticals Market Forecast ($bn) 2019-2029

Figure 5.42 Africa OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.43 Other Countries OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029

Figure 5.44 Rest of the World OTC Pharmaceuticals Market Forecast by Product: Revenue ($bn) 2019-2029

Figure 5.45 Rest of the World OTC Pharmaceuticals Market by Product, Market Share (%), 2018

Figure 6.1 Porter’s Five Analysis of the OTC Pharmaceuticals Market, 2018

Figure 7.1 Bayer AG: Revenue ($million), 2014-2018

Figure 7.2 Bayer AG: Product Segments Share (%), 2018

Figure 7.3 Bayer AG: Geographic Presence Share (%), 2018

Figure 7.4 GlaxoSmithKline PLC: Revenue ($million), 2014-2018

Figure 7.5 GlaxoSmithKline PLC: Product Segments Share (%), 2018

Figure 7.6 GlaxoSmithKline PLC: Geographical Presence Share (%), 2018

Figure 7.7 Johnson & Johnson: Revenue ($million), 2014-2018

Figure 7.8 Johnson & Johnson: Product Segments Share (%), 2018

Figure 7.9 Johnson & Johnson: Geographical Presence Share (%), 2018

Figure 7.10 Perrigo Company PLC, Revenue, ($million), 2014-2018

Figure 7.11 Perrigo Company PLC: Product Segments Share (%), 2018

Figure 7.12 Perrigo Company PLC: Geographical Presence Share (%), 2018

Figure 7.13 Daiichi Sankyo Company Limited: Revenue ($million), 2014-2018

Figure 7.14 Daiichi Sankyo Company Limited: Geographical Presence Share (%), 2018

Figure 7.15 Pfizer Inc.: Revenue ($million), 2014-2018

Figure 7.16 Pfizer Inc.: Product Segments Share (%), 2018

Figure 7.17 Pfizer Inc.: Geographical Presence Share (%), 2018

Figure 7.18 The Procter & Gamble Company: Revenue ($million), 2014-2018

Figure 7.19 The Procter & Gamble Company: Product Segments Share (%), 2018

Figure 7.20 The Procter & Gamble Company: Geographical Presence Share (%), 2018

Figure 7.21 Sanofi S.A.: Revenue ($million), 2014-2018

Figure 7.22 Sanofi S.A.: Product Segments Share (%), 2018

Figure 7.23 Sanofi S.A.: Geographical Presence Share (%), 2018

Figure 7.24 Reckitt Benckiser Group PLC: Revenue ($million), 2014-2018

Figure 7.25 Reckitt Benckiser Group PLC: Product Segments Share (%), 2018

Figure 7.26 Reckitt Benckiser Group PLC: Geographical Presence Share (%), 2018

Figure 7.27 Cipla Inc.: Revenue: ($million), 2014-2018

Figure 7.28 Cipla Inc.: Product Segments Share (%), 2018

Figure 7.29 AstraZeneca plc: Revenue ($million), 2014-2018

Figure 7.30 AstraZeneca plc: Product Segments Share (%), 2018

Figure 7.31 AstraZeneca plc: Geographical Presence Share (%), 2018

Figure 7.32 Bristol Myers Squibb: Revenue ($million), 2014-2018

Figure 7.33 Bristol Myers Squibb: Product Segments Share (%), 2018

Figure 7.34 Bristol Myers Squibb: Geographical Presence Share (%), 2018

Figure 7.35 Dr. Reddy’s Laboratories Limited: Revenue ($million), 2014-2018

Figure 7.36 Dr. Reddy’s Laboratories Limited: Product Segments Share (%), 2018

Figure 7.37 Dr. Reddy’s Laboratories Limited: Geographical Presence Share (%), 2018

Figure 7.38 Eisai Co., Ltd.: Revenue ($million), 2014-2018

Figure 7.39 Eisai Co., Ltd.: Product Segments Share (%), 2018

Figure 7.40 Eisai Co., Ltd.: Geographical Presence Share (%), 2018

Figure 7.41 Mylan N.V.: Revenue ($million), 2014-2018

Figure 7.42 Mylan N.V.: Product Segments Share (%), 2018

Figure 7.43 Mylan N.V.: Geographical Presence Share (%), 2018

Figure 8.1 Global OTC Pharmaceuticals Market Revenue, by Product Type ($bn), 2019-2029

Figure 8.2 Global OTC Pharmaceuticals Market: Revenue by Geography ($bn), 2019-2029

23andMe

Abbott Medical Optics

Achelios Therapeutics, Inc.

Acrux

Agrifen

AiPing Pharmaceutical

Akron Pharmaceuticals

Alka Seltzer Vitacilina

Allegiant Health

Alliance Boots

Alvogen pharmaceuticals company

American Health

AmerisourceBergen

Amol Pharmaceuticals Private Limited

Apotex

Arena Pharmaceuticals

Aspen Australia

Aspen Global Inc.

Aspirina

Astellas Pharma US, Inc.

AstraZeneca PLC

Bal Pharma ltd.

Bayer

BePharBel

Beximco Pharmaceuticals

Binnopharm

Biocartis Group NV

Biocon Ltd.

BioGaia

BionTech AG

Bliss GVS Pharma Ltd.

Boehringer Ingelheim

Bristol-Myres Squibb

Bukwang Pharm. Co., Ltd.

Canagen Pharmaceuticals, Inc.

Cardinal Health

Carlyle Group

Catalent Pharma Solutions

Celesio

China Resources

Chr. Hansen

Cialis

Cleveland Clinic

CoLucid Pharmaceuticals

CR Pharmaceutical

Crescent Pharma

Curis, Inc.

Daiichi Sankyo

Delavau Pharmaceutical Partners

Dihon Pharmaceutical Group Co Ltd.

Ducere Pharma

Eisai Co., Ltd.

Electrolit

Eli Lilly

FameWave Ltd.

Flamel

Fujifilm Kyowa Kirin Biologics Co. Ltd.

GCP Laboratories

Genomma Lab

GIC Holdings

Gilead Medicines

GSK

Guangzhou Pharmaceutical Company, Ltd.

Guardian Drug Company

Haplogen GmbH

Hiran Agroceuticals Private Limited

Hi-Tech Pharmaceuticals

Im Co., Ltd

iNova Pharmaceuticals

Insight

Integral Molecular, Inc.

Ion Labs

Jagdale Healthcare

Janssen Pharmaceuticals, Inc.

Johnson & Johnson

Juno Pharmaceuticals

Kowa

Lion

Lipa Pharmaceuticals

LNK International, Inc.

Marksans Pharma

Mayne Pharma

McKesson Corporation

MCP3

Mead Johnson Nutrition Company

Merck

Merck Seron

Moberg Pharma

Momenta Pharmaceuticals, Inc.

Morphic Therapeutic

Mylan N.V.

Nektar Therapeutics

Nektar Therapeutics

NeoStrata Company, Inc.

Nepstar

Nexgen Pharma Inc.

Next

Nihon Eisai Co., Ltd.

Novartis JV

Olainfarm

Olive Healthcare

Omega Pharma Invest N.V.

Ono Pharmaceutical Co., Ltd.

ORJagdale Healthcare SL

ORSL

Pedialyte

Perrigo Company PLC

Pfizer

Phoenix

Procter & Gamble

ProPhase Labs, Inc.

Purzer Pharmaceutical Co., Ltd.

Ranir Global Holdings LLC

Reckitt Benckiser

Rohto

Sal de Uvas Picot

Samson Pharmaceuticals, Inc.

Sanofi

Sarvotham Care Limited

Sato

Sentiss Pharmaceuticals, LLC

Shanghai Pharmaceuticals

Sinopharm

Sterling Pharmaceutical

Suerox

Taisho

Takeda

Target

TB Alliance

Tempra

Teva

Theravance Biopharma, Inc.

Transgene SA

Trividia Manufacturing Solutions, Inc.

TSI Pharmaceuticals

Valenta Pharm

Verily Life Sciences LLC

Vifor Pharma

Vista Pharmaceuticals

Walmart

Wellona Pharma

List of Organisations Mentioned in the Report

ANVISA

Association of the European Self-Medication Industry

Canadian Institute for Health Information

Center for Drug Evaluation and Research

European Medicines Agency

French Ministry of Health

Kyoto University

MD Anderson Cancer Center

Medicines and Healthcare products Regulatory Agency

Ministry of Health, Labour and Welfare

Pharmaceutical and Medical Devices Agency

Sarah Cannon Research Institute

State Food and Drug Administration

Download sample pages

Complete the form below to download your free sample pages for Global OTC Pharmaceutical Market Forecast 2019-2029

Download sample pages

Complete the form below to download your free sample pages for Global OTC Pharmaceutical Market Forecast 2019-2029

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033

The global Allergy Immunotherapy market is projected to grow at a CAGR of 7.6% by 2033

31 May 2023

READ

Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033

The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.

26 May 2023

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033

The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033

24 May 2023

READ

Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033

The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033

23 May 2023

READ

Industries > Pharma > Global OTC Pharmaceutical Market Forecast 2019-2029

Back to Pharma Reports

Global OTC Pharmaceutical Market Forecast 2019-2029

Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others

Download sample pages

Related reports

Pharmaceutical Contract Manufacturing Market 2019-2029

Indian Pharmaceutical Market Forecast 2019-2029

Global Diagnostic Imaging Market Forecast 2019-2029

Biologics Market Trends and Forecasts 2019-2029

Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2019-2029

Global Rare Disease Drugs Market Forecast 2019-2029

Orphan Drugs Market Report 2018-2028

Top 25 Dermatological Drugs Manufacturers 2019

Global Biosimilars and Follow-On Biologics Market 2019-2029

Collagen Market Report 2019-2029

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033

Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033

Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033

Our Clients